Literature DB >> 25304041

Oligoastrocytomas: throwing the baby out with the bathwater?

Paul Wilcox1, Cheryl C Y Li, Maggie Lee, Brindha Shivalingam, Jeffrey Brennan, Catherine M Suter, Kimberley Kaufman, Trina Lum, Michael E Buckland.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25304041     DOI： 10.1007/s00401-014-1353-4

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN： 0001-6322            Impact factor:   17.088


× No keyword cloud information.
  17 in total

Review 1.  Neuro-Oncology and Radiogenomics: Time to Integrate?

Authors:  A Lasocki; M A Rosenthal; S J Roberts-Thomson; A Neal; K J Drummond
Journal:  AJNR Am J Neuroradiol       Date:  2020-09-10       Impact factor: 3.825

2.  The Misclassification of Diffuse Gliomas: Rates and Outcomes.

Authors:  J Bryan Iorgulescu; Matthew Torre; Maya Harary; Timothy R Smith; Ayal A Aizer; David A Reardon; Jill S Barnholtz-Sloan; Arie Perry
Journal:  Clin Cancer Res       Date:  2019-01-11       Impact factor: 12.531

3.  Oligodendrogliomas in pediatric and teenage patients only rarely exhibit molecular markers and patients have excellent survivals.

Authors:  Yan-Xi Li; Abudumijiti Aibaidula; Zhifeng Shi; Hong Chen; Kay Ka-Wai Li; Nellie Yuk-Fei Chung; Ryan Rui Yang; Danny Tat-Ming Chan; Wai Sang Poon; Ka Lok Ryan Lee; Ying Mao; Jinsong Wu; Aden Ka-Yin Chan; Liangfu Zhou; Ho-Keung Ng
Journal:  J Neurooncol       Date:  2018-05-14       Impact factor: 4.130

4.  Genomic analysis of the origins and evolution of multicentric diffuse lower-grade gliomas.

Authors:  Josie Hayes; Yao Yu; Llewellyn E Jalbert; Tali Mazor; Lindsey E Jones; Matthew D Wood; Kyle M Walsh; Henrik Bengtsson; Chibo Hong; Stefan Oberndorfer; Thomas Roetzer; Ivan V Smirnov; Jennifer L Clarke; Manish K Aghi; Susan M Chang; Sarah J Nelson; Adelheid Woehrer; Joanna J Phillips; David A Solomon; Joseph F Costello
Journal:  Neuro Oncol       Date:  2018-04-09       Impact factor: 12.300

5.  Diagnostic revision of 206 adult gliomas (including 40 oligoastrocytomas) based on ATRX, IDH1/2 and 1p/19q status.

Authors:  Marta Mellai; Laura Annovazzi; Rebecca Senetta; Carmine Dell'Aglio; Marta Mazzucco; Paola Cassoni; Davide Schiffer
Journal:  J Neurooncol       Date:  2016-10-28       Impact factor: 4.506

Review 6.  Oligodendroglioma: pathology, molecular mechanisms and markers.

Authors:  Pieter Wesseling; Martin van den Bent; Arie Perry
Journal:  Acta Neuropathol       Date:  2015-05-06       Impact factor: 17.088

7.  Not all 1p/19q non-codeleted oligodendroglial tumors are astrocytic.

Authors:  Yan-Xi Li; Zhifeng Shi; Abudumijiti Aibaidula; Hong Chen; Qisheng Tang; Kay Ka-Wai Li; Nellie Yuk-Fei Chung; Danny Tat-Ming Chan; Wai Sang Poon; Ying Mao; Jinsong Wu; Liangfu Zhou; Aden Ka-Yin Chan; Ho-Keung Ng
Journal:  Oncotarget       Date:  2016-10-04

8.  IDH mutation, 1p19q codeletion and ATRX loss in WHO grade II gliomas.

Authors:  Heather E Leeper; Alissa A Caron; Paul A Decker; Robert B Jenkins; Daniel H Lachance; Caterina Giannini
Journal:  Oncotarget       Date:  2015-10-06

9.  Reconstructing the molecular life history of gliomas.

Authors:  Floris P Barthel; Pieter Wesseling; Roel G W Verhaak
Journal:  Acta Neuropathol       Date:  2018-04-03       Impact factor: 17.088

10.  A dual-genotype oligoastrocytoma with histologic, molecular, radiological and time-course features.

Authors:  Mac Lean P Nasrallah; Arati Desai; Donald M O'Rourke; Lea F Surrey; Joel M Stein
Journal:  Acta Neuropathol Commun       Date:  2020-07-20       Impact factor: 7.801
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.